{"count": 3, "results": [{"_id": "40736696", "pmid": 40736696, "title": "Simvastatin addition to standard of care improves long-term survival in patients with cirrhosis after variceal bleed: An open label randomized controlled trial.", "journal": "Am J Gastroenterol", "authors": ["Rana R", "Tabish M", "Agarwal S", "Bayye R", "Ahmed S", "Gunjan D", "Sharma S", "Saraya A"], "date": "2025-07-31T00:00:00Z", "doi": "10.14309/ajg.0000000000003689", "meta_date_publication": "2025 Jul 31", "meta_volume": "", "meta_issue": "", "meta_pages": "", "score": 50247.57, "text_hl": "Incidence of @DISEASE_Ascites @DISEASE_MESH:D001201 @@@ascites@@@(sub-distributional HR):0.60[0.39-0.92] and spontaneous @DISEASE_Peritonitis @DISEASE_MESH:D010538 @@@bacterial peritonitis@@@ (sHR:0.30[0.11-0.81] was lower in @<m>CHEMICAL_Simvastatin</m> @CHEMICAL_MESH:D019821 @@@simvastatin@@@ arm. All cause decompensation(sHR:0.74[0.52-1.05]), rebleeding(sHR:0.87[0.57-1.34]), @<m>DISEASE_Hepatic_Encephalopathy</m> @DISEASE_MESH:D006501 @@@hepatic encephalopathy@@@(sHR:0.71[0.42-1.19) and @DISEASE_Acute_On_Chronic_Liver_Failure @DISEASE_MESH:D065290 @@@acute-on-chronic liver-failure@@@ (sHR:0.65[0.39-1.10]) were comparable in both arms. ", "citations": {"NLM": "Rana R, Tabish M, Agarwal S, Bayye R, Ahmed S, Gunjan D, Sharma S, Saraya A. Simvastatin addition to standard of care improves long-term survival in patients with cirrhosis after variceal bleed: An open label randomized controlled trial. Am J Gastroenterol. 2025 Jul 31;():. PMID: 40736696", "BibTeX": "@article{40736696, title={Simvastatin addition to standard of care improves long-term survival in patients with cirrhosis after variceal bleed: An open label randomized controlled trial.}, author={Rana R and Tabish M and Agarwal S and Bayye R and Ahmed S and Gunjan D and Sharma S and Saraya A}, journal={Am J Gastroenterol}}"}}, {"_id": "17573832", "pmid": 17573832, "title": "Simvastatin for rats with thioacetamide-induced liver failure and encephalopathy.", "journal": "J Gastroenterol Hepatol", "authors": ["Huang HC", "Wang SS", "Lee FY", "Chan CY", "Chang FY", "Lin HC", "Chu CJ", "Chen YC", "Lee SD"], "date": "2008-07-01T00:00:00Z", "doi": "10.1111/j.1440-1746.2007.04988.x", "meta_date_publication": "2008 Jul", "meta_volume": "23", "meta_issue": "7 Pt 2", "meta_pages": "e236-42", "score": 50051.734, "text_hl": "The aim of this study was to assess the effects of @<m>CHEMICAL_Simvastatin</m> @CHEMICAL_MESH:D019821 @@@simvastatin@@@ on @SPECIES_10116 @@@rats@@@ with @CHEMICAL_Thioacetamide @CHEMICAL_MESH:D013853 @@@TAA@@@-induced @DISEASE_Chemical_and_Drug_Induced_Liver_Injury @DISEASE_MESH:D056486 @@@acute liver damage@@@ and @<m>DISEASE_Hepatic_Encephalopathy</m> @DISEASE_MESH:D006501 @@@hepatic encephalopathy@@@. ", "citations": {"NLM": "Huang HC, Wang SS, Lee FY, Chan CY, Chang FY, Lin HC, Chu CJ, Chen YC, Lee SD. Simvastatin for rats with thioacetamide-induced liver failure and encephalopathy. J Gastroenterol Hepatol. 2008 Jul;23(7 Pt 2):e236-42. PMID: 17573832", "BibTeX": "@article{17573832, title={Simvastatin for rats with thioacetamide-induced liver failure and encephalopathy.}, author={Huang HC and Wang SS and Lee FY and Chan CY and Chang FY and Lin HC and Chu CJ and Chen YC and Lee SD}, journal={J Gastroenterol Hepatol}, volume={23}, number={7 Pt 2}, pages={e236-42}}"}}, {"_id": "29064029", "pmid": 29064029, "title": "The portal hypertension syndrome: etiology, classification, relevance, and animal models.", "journal": "Hepatol Int", "authors": ["Bosch J", "Iwakiri Y"], "date": "2018-02-01T00:00:00Z", "doi": "10.1007/s12072-017-9827-9", "meta_date_publication": "2018 Feb", "meta_volume": "12", "meta_issue": "Suppl 1", "meta_pages": "1-10", "score": 50036.91, "text_hl": "RESULTS: The aim of treatment in compensated @DISEASE_Fibrosis @DISEASE_MESH:D005355 @@@cirrhosis@@@ is preventing clinical decompensation, the more frequent event being @DISEASE_Ascites @DISEASE_MESH:D001201 @@@ascites@@@, followed by @DISEASE_Varicose_Veins @DISEASE_MESH:D014648 @@@variceal bleeding@@@ and @<m>DISEASE_Hepatic_Encephalopathy</m> @DISEASE_MESH:D006501 @@@hepatic encephalopathy@@@. ", "citations": {"NLM": "Bosch J, Iwakiri Y. The portal hypertension syndrome: etiology, classification, relevance, and animal models. Hepatol Int. 2018 Feb;12(Suppl 1):1-10. PMID: 29064029", "BibTeX": "@article{29064029, title={The portal hypertension syndrome: etiology, classification, relevance, and animal models.}, author={Bosch J and Iwakiri Y}, journal={Hepatol Int}, volume={12}, number={Suppl 1}, pages={1-10}}"}}]}